Plus, these surprise drugs constitute perhaps the most exciting treatment possibility ever seen in ME/CFS, FM, long COVID, and related diseases
Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes/type 2 diabetes: a randomized, single-blinded, placebo-controlled study
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or any advice relating to your health
However, they were comparing exenatide and liraglutide to placebo and other diabetes medications that lower glucose levels
Please enter your contact details below and the reason for your discovery call and we will get back to you to arrange a suitable time for your FREE 15 Minute Discovery Call
This is one reason some explore split dosing strategies